Antibiotic Resistance

Antibiotic overprescription has lead to a rise in antimicrobial resistance, posing a clear and present danger to modern medicine and worldwide health. We strive to empower our cients with tools to make informed medical decisions and reduce that threat.

Antimicrobial Resistance Poses a Global Health Threat


Worldwide Annual Deaths Due to Antimicrobial Resistance


of Outpatient Antibiotic Prescriptions Are Unnecessary or Inappropriate


Estimated Additional Cost to U.S. Healthcare System Each Year

We actively engage in partnerships and research initiatives to better understand antibiotic resistance. By collaborating with medical professionals, academic institutions, and industry partners, our goal is to empower individuals, healthcare providers, and organizations with the knowledge and resources needed to make informed decisions about antibiotic use and infection prevention methods to reduce the threat of antibiotic resistance. Together, we can work towards preserving the effectiveness of antibiotics for future generations and ensuring the continued success of modern medicine.

Our antibiotic resistance service is designed to address the challenges posed by over prescription and the need for customized antibiotic dosing. By leveraging advanced diagnostic techniques, we offer several clinical advantages that can significantly impact patient care and outcomes.

Clinical Advantages: 

  • Timely Diagnosis and Treatment:

    Our service provides high-speed results within 24 to 48 hours after the specimen arrives at the laboratory. This helps prevent delays in diagnosis and enables healthcare providers to initiate appropriate treatment promptly, leading to improved patient outcomes.

  • Simultaneous Detection of Polymicrobial Infections:

    We can identify polymicrobial infections, which involve multiple pathogens, simultaneously. This comprehensive approach ensures that all relevant pathogens are detected, allowing for targeted treatment strategies.

  • Antibiotic Resistance Gene Identification:

    Identifying specific antibiotic resistance genes, such as B-Lactam Resistance, Carbapenem, and Vancomycin resistance, is essential in guiding treatment decisions and selecting the most effective antibiotics. This information enables the selection of antibiotics that target specific resistance mechanisms, increasing the likelihood of successful treatment and reducing the risk of treatment failure. Ultimately, our service helps optimize treatment strategies and improve patient outcomes in the face of antibiotic resistance.

  • Less Susceptibility to Concurrent Antibiotic Therapy:

    Our diagnostic techniques are designed to be less susceptible to interference from concurrent antibiotic therapy. This means that even if a patient is already receiving antibiotics, our service can still provide accurate results, ensuring that appropriate adjustments can be made if necessary.

  • Reduction of Unnecessary Drug Exposure and Adverse Events:

    By providing precise information about the pathogens and their resistance profiles, our service helps reduce unnecessary exposure to broad-spectrum antibiotics. This targeted approach minimizes the risk of adverse events associated with antibiotics and supports more effective and efficient treatment.

  • Decreased Progression and Spread of Infection:

    Early and accurate identification of pathogens and their resistance patterns allows for more effective containment and management of infections. This can help prevent the progression of infections, reduce the spread of antibiotic-resistant organisms, and improve overall infection control efforts.

  • Improved Selection of Narrow-Spectrum Antibiotics:

    With detailed information about the pathogens and their resistance profiles, healthcare providers can select narrow-spectrum antibiotics whenever possible. This targeted approach helps minimize the disruption of the patient’s natural microbiota and reduce the development of further antibiotic resistance.

  • Cost-Effective Treatment Decisions:

    By providing accurate and comprehensive information, our service equips clinicians with the data they need to make cost-effective treatment decisions. This includes selecting the most appropriate antibiotics, optimizing dosing regimens, and minimizing the need for empirical or broad-spectrum therapies.

  • Easily Accessible Results:

    Our service offers convenient accessibility to results through multiple channels, including mobile applications, web portals, or integration with electronic medical records (EMRs). This ensures that healthcare providers can access the information seamlessly, allowing for efficient decision-making and patient management.

By utilizing our antibiotic resistance service, healthcare providers can enhance their ability to make informed treatment decisions, optimize antibiotic use, and mitigate the risks associated with over-prescription. Ultimately, this leads to improved patient care, reduced hospitalizations, and better overall health outcomes.

We Include Arkstone Report for Every Client at No Additional Cost

Every Arkstone report includes Antimicrobial Resistance ArkScore that measures levels of antimicrobial resistance expressed in the detected organisms. Lower scores denote low resistance, in which case the antibiotic of choice can be given with less concern about adverse outcomes. A higher score indicates higher levels of resistance, limiting the antibiotic options available, increasing risk to the patient.